These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

528 related items for PubMed ID: 9186000

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Oncostatin M (OM) promotes the growth of DU 145 human prostate cancer cells, but not PC-3 or LNCaP, through the signaling of the OM specific receptor.
    Mori S, Murakami-Mori K, Bonavida B.
    Anticancer Res; 1999; 19(2A):1011-5. PubMed ID: 10368647
    [Abstract] [Full Text] [Related]

  • 6. Oncostatin M is a differentiation factor for myeloid leukemia cells.
    Bruce AG, Hoggatt IH, Rose TM.
    J Immunol; 1992 Aug 15; 149(4):1271-5. PubMed ID: 1380037
    [Abstract] [Full Text] [Related]

  • 7. Oncostatin M-mediated transcriptional suppression of the c-myc gene in breast cancer cells.
    Spence MJ, Vestal RE, Liu J.
    Cancer Res; 1997 Jun 01; 57(11):2223-8. PubMed ID: 9187125
    [Abstract] [Full Text] [Related]

  • 8. The expression of p53 tumor suppressor gene in breast cancer cells is down-regulated by cytokine oncostatin M.
    Liu J, Li C, Ahlborn TE, Spence MJ, Meng L, Boxer LM.
    Cell Growth Differ; 1999 Oct 01; 10(10):677-83. PubMed ID: 10547071
    [Abstract] [Full Text] [Related]

  • 9. An unexpected biochemical and functional interaction between gp130 and the EGF receptor family in breast cancer cells.
    Grant SL, Hammacher A, Douglas AM, Goss GA, Mansfield RK, Heath JK, Begley CG.
    Oncogene; 2002 Jan 17; 21(3):460-74. PubMed ID: 11821958
    [Abstract] [Full Text] [Related]

  • 10. Oncostatin M binds the high-affinity leukemia inhibitory factor receptor.
    Gearing DP, Bruce AG.
    New Biol; 1992 Jan 17; 4(1):61-5. PubMed ID: 1536831
    [Abstract] [Full Text] [Related]

  • 11. Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.
    Underhill-Day N, Heath JK.
    Cancer Res; 2006 Nov 15; 66(22):10891-901. PubMed ID: 17108126
    [Abstract] [Full Text] [Related]

  • 12. Early events in the antiproliferative action of tumor necrosis factor are similar to the early events in epidermal growth factor growth stimulation.
    Donato NJ, Ince C, Rosenblum MG, Gallick GE.
    J Cell Biochem; 1989 Nov 15; 41(3):139-57. PubMed ID: 2482293
    [Abstract] [Full Text] [Related]

  • 13. Phosphatidylinositol 3-kinase recruitment by p185erbB-2 and erbB-3 is potently induced by neu differentiation factor/heregulin during mitogenesis and is constitutively elevated in growth factor-independent breast carcinoma cells with c-erbB-2 gene amplification.
    Ram TG, Ethier SP.
    Cell Growth Differ; 1996 May 15; 7(5):551-61. PubMed ID: 8732665
    [Abstract] [Full Text] [Related]

  • 14. Inhibition of breast cancer cell growth in vitro by a tyrosine kinase inhibitor.
    Reddy KB, Mangold GL, Tandon AK, Yoneda T, Mundy GR, Zilberstein A, Osborne CK.
    Cancer Res; 1992 Jul 01; 52(13):3636-41. PubMed ID: 1617636
    [Abstract] [Full Text] [Related]

  • 15. The critical role of the PE21 element in oncostatin M-mediated transcriptional repression of the p53 tumor suppressor gene in breast cancer cells.
    Li C, Ahlborn TE, Tokita K, Boxer LM, Noda A, Liu J.
    Oncogene; 2001 Dec 13; 20(57):8193-202. PubMed ID: 11781835
    [Abstract] [Full Text] [Related]

  • 16. Regulation of EGR-1, c-jun, and c-myc gene expression by oncostatin M.
    Liu J, Clegg CH, Shoyab M.
    Cell Growth Differ; 1992 May 13; 3(5):307-13. PubMed ID: 1633113
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of phorbol ester on epidermal growth factor receptors in estrogen receptor-positive and -negative breast cancer cell lines.
    Koga M, Musgrove EA, Sutherland RL.
    Cancer Res; 1990 Aug 15; 50(16):4849-55. PubMed ID: 2379149
    [Abstract] [Full Text] [Related]

  • 18. Quantitative dissociation between EGF effects on c-myc and c-fos gene expression, DNA synthesis, and epidermal growth factor receptor tyrosine kinase activity.
    Hauguel-DeMouzon S, Csermely P, Zoppini G, Kahn CR.
    J Cell Physiol; 1992 Jan 15; 150(1):180-7. PubMed ID: 1730782
    [Abstract] [Full Text] [Related]

  • 19. Inhibition by interleukin 4 of leukemia inhibitory factor-, interleukin 6-, and dexamethasone-induced differentiation of mouse myeloid leukemia cells: role of c-myc and junB proto-oncogenes.
    Kasukabe T, Okabe-Kado J, Hozumi M, Honma Y.
    Cancer Res; 1994 Jan 15; 54(2):592-7. PubMed ID: 8275499
    [Abstract] [Full Text] [Related]

  • 20. Expression and function of members of the cytokine receptor superfamily on breast cancer cells.
    Douglas AM, Goss GA, Sutherland RL, Hilton DJ, Berndt MC, Nicola NA, Begley CG.
    Oncogene; 1997 Feb 13; 14(6):661-9. PubMed ID: 9038373
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.